Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019
Abstract. Background:. Gallbladder and biliary tract cancer (GBTC) has greatly damaged the health of patients and is accompanied by a dismal prognosis. The worldwide distribution of GBTC shows extensive variance and the updated data in China is lacking. This study was to determine the current status...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2022-07-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002258 |
| _version_ | 1811204255882674176 |
|---|---|
| author | Shimin Chen Ke Han Yang Song Shaohua Liu Xuehang Li Shengshu Wang Haowei Li Rongrong Li Jianhua Wang Yao He Miao Liu Jing Ni |
| author_facet | Shimin Chen Ke Han Yang Song Shaohua Liu Xuehang Li Shengshu Wang Haowei Li Rongrong Li Jianhua Wang Yao He Miao Liu Jing Ni |
| author_sort | Shimin Chen |
| collection | DOAJ |
| description | Abstract. Background:. Gallbladder and biliary tract cancer (GBTC) has greatly damaged the health of patients and is accompanied by a dismal prognosis. The worldwide distribution of GBTC shows extensive variance and the updated data in China is lacking. This study was to determine the current status, trends, and predictions in the burden of GBTC over the past 30 years in China.
Methods:. This was a descriptive, epidemiological, secondary analysis of the Global Burden of Disease, Injuries, and Risk Factor Study 2019 data. Data including incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of GBTC in China by year, age, and sex were assessed. Joinpoint regression analysis was conducted to evaluate trends of disease burden due to GBTC from 1990 to 2019. Nordpred age-period-cohort analysis was applied for the projection of mortality and incidence due to GBTC from 2019 to 2044.
Results:. Nationally, there were 38,634 (95% uncertainty interval [UI]: 27,350–46,512) new cases and 47,278 (95% UI: 32,889–57,229) patients due to GBTC, causing 34,462 (95% UI: 25,220–41,231) deaths, and 763,584 (95% UI: 566,755–920,493) DALYs in 2019. Both cases and rates of burden owing to GBTC were heavier among males and at old age. From 1990 to 2019, the age-standardized rates of incidence, prevalence, mortality, and DALYs of GBTC generally increased from 1990 to 2019, with average annual percentage change at 0.8% (95% confidential interval [CI]: 0.6–1.0%), 1.3% (95% CI: 1.1–1.5%), 0.4% (95% CI: 0.2–0.6%), and 0.2% (95% CI: 0.1–0.4%), respectively. Even though the age-standardized incidence rate and age-standardized mortality rate in both sexes were predicted to decline gradually from 2019 to 2044, the number of new cases and deaths were expected to grow steadily.
Conclusions:. GBTC is becoming a major health burden in China, particularly among males and older individuals. Given the aging population and increasing burden, effective strategies and measurements are urged to prevent or reduce the number of new cases and deaths of GBTC. |
| first_indexed | 2024-04-12T03:08:50Z |
| format | Article |
| id | doaj.art-7443d00d35734ea99faec2edc35bf617 |
| institution | Directory Open Access Journal |
| issn | 0366-6999 2542-5641 |
| language | English |
| last_indexed | 2024-04-12T03:08:50Z |
| publishDate | 2022-07-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj.art-7443d00d35734ea99faec2edc35bf6172022-12-22T03:50:25ZengWolters KluwerChinese Medical Journal0366-69992542-56412022-07-01135141697170610.1097/CM9.0000000000002258202207200-00009Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019Shimin ChenKe HanYang SongShaohua LiuXuehang LiShengshu WangHaowei LiRongrong LiJianhua WangYao HeMiao LiuJing NiAbstract. Background:. Gallbladder and biliary tract cancer (GBTC) has greatly damaged the health of patients and is accompanied by a dismal prognosis. The worldwide distribution of GBTC shows extensive variance and the updated data in China is lacking. This study was to determine the current status, trends, and predictions in the burden of GBTC over the past 30 years in China. Methods:. This was a descriptive, epidemiological, secondary analysis of the Global Burden of Disease, Injuries, and Risk Factor Study 2019 data. Data including incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of GBTC in China by year, age, and sex were assessed. Joinpoint regression analysis was conducted to evaluate trends of disease burden due to GBTC from 1990 to 2019. Nordpred age-period-cohort analysis was applied for the projection of mortality and incidence due to GBTC from 2019 to 2044. Results:. Nationally, there were 38,634 (95% uncertainty interval [UI]: 27,350–46,512) new cases and 47,278 (95% UI: 32,889–57,229) patients due to GBTC, causing 34,462 (95% UI: 25,220–41,231) deaths, and 763,584 (95% UI: 566,755–920,493) DALYs in 2019. Both cases and rates of burden owing to GBTC were heavier among males and at old age. From 1990 to 2019, the age-standardized rates of incidence, prevalence, mortality, and DALYs of GBTC generally increased from 1990 to 2019, with average annual percentage change at 0.8% (95% confidential interval [CI]: 0.6–1.0%), 1.3% (95% CI: 1.1–1.5%), 0.4% (95% CI: 0.2–0.6%), and 0.2% (95% CI: 0.1–0.4%), respectively. Even though the age-standardized incidence rate and age-standardized mortality rate in both sexes were predicted to decline gradually from 2019 to 2044, the number of new cases and deaths were expected to grow steadily. Conclusions:. GBTC is becoming a major health burden in China, particularly among males and older individuals. Given the aging population and increasing burden, effective strategies and measurements are urged to prevent or reduce the number of new cases and deaths of GBTC.http://journals.lww.com/10.1097/CM9.0000000000002258 |
| spellingShingle | Shimin Chen Ke Han Yang Song Shaohua Liu Xuehang Li Shengshu Wang Haowei Li Rongrong Li Jianhua Wang Yao He Miao Liu Jing Ni Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019 Chinese Medical Journal |
| title | Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019 |
| title_full | Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019 |
| title_fullStr | Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019 |
| title_full_unstemmed | Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019 |
| title_short | Current status, trends, and predictions in the burden of gallbladder and biliary tract cancer in China from 1990 to 2019 |
| title_sort | current status trends and predictions in the burden of gallbladder and biliary tract cancer in china from 1990 to 2019 |
| url | http://journals.lww.com/10.1097/CM9.0000000000002258 |
| work_keys_str_mv | AT shiminchen currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT kehan currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT yangsong currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT shaohualiu currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT xuehangli currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT shengshuwang currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT haoweili currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT rongrongli currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT jianhuawang currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT yaohe currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT miaoliu currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 AT jingni currentstatustrendsandpredictionsintheburdenofgallbladderandbiliarytractcancerinchinafrom1990to2019 |